Industry Insights: Healthcare 13th May
This week’s round of insights focuses on three recent hot topics in the healthcare industry. Should we worry about a hantavirus outbreak? A hantavirus outbreak linked to a cruise ship has recently raised concerns around infectious disease surveillance and outbreak containment in travel settings. According to reports from the World Health Organization (WHO), several passengers […]
Industry Insights: Healthcare 15th April
In this week’s round of insights, we highlight three recent talking points and findings in the healthcare industry. The effects of the brain–gut–skin axis in chronic skin disease A recent study from Frontiers in Immunology has found that the brain–gut–skin axis has a major effect in the development of chronic inflammatory skin conditions, including […]
Industry Insights: Healthcare 25th March
In this week’s insights, we present three recent talking points and findings in the healthcare industry. FDA approves first generic fluticasone inhaler for asthma treatment The US Food and Drug Administration (FDA) has approved the first generic version of fluticasone propionate (Flovent HFA) inhalation aerosol. This approval marks a major step towards improving access to […]
Industry Insights: Healthcare Feb 25th
Industry Insights: Healthcare This round of #healthcare insights highlights three important developments that promise to better the future of rare disease diagnosis, regulation and education. A newly proposed pathway for ultra-rare therapies The US Food and Drug Administration (FDA) has issued a framework on a new approval pathway for highly targeted, individualised genome and RNA […]
Industry Insights: Healthcare Feb 4th
Industry Insights: Healthcare In this week’s insights, we present three recent talking points and findings in the healthcare industry. 𝗖𝗼𝗹𝗼𝗿𝗲𝗰𝘁𝗮𝗹 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗿𝗶𝘀𝗲 𝗮𝗺𝗼𝗻𝗴𝘀𝘁 𝘆𝗼𝘂𝗻𝗴𝗲𝗿 𝗮𝗱𝘂𝗹𝘁𝘀 Colorectal cancer (CRC) has become the leading cause of cancer-related death in adults younger than 50 years in the US. A recent analysis from JAMA pointed to […]
Industry Insights: Healthcare 14th January
Industry Insights: Healthcare In this year’s first round of #healthcare insights, we highlight a much anticipated drug approval and two recent findings in the healthcare industry. FDA approves the first GLP-1 pill for obesity treatment The US Food and Drug Administration (FDA) has approved the first once-daily oral semaglutide (Wegovy; Novo Nordisk) pill. This approval […]
Industry Insights: Healthcare 10th December
Industry Insights: Healthcare In this week’s round of insights, we highlight three of the most recent developments and findings in the healthcare industry. WHO publishes GLP-1 guidelines for obesity treatment The World Health Organization (WHO) has released its first global guidelines endorsing long-term use of GLP-1 receptor agonists for adults with obesity. The guidance recognises […]
Industry Insights: Healthcare 19th November
Industry Insights Healthcare This week’s insights post focuses on three of the most recent developments and discussion points in the healthcare industry. FDA removes “black box” warning from HRT products for menopause In January 2003, the FDA issued “black box” warnings for HRT medications based on the Women’s Health Initiative study with warnings about the […]
Industry Insights: Healthcare 15th October
Industry Insights Healthcare: 17/10/25 This week’s round of insights highlights three of the most recent developments and findings in the healthcare industry. Physical activity and vaccination may protect against long COVID A new Frontiers in Public Health study using data from over 433,000 US adults has highlighted key factors associated with protection against long COVID. […]
Industry Insights: Healthcare 24th September
Industry Insights: Healthcare This week’s insights post focuses on three of the most recent developments and discussion points in the healthcare industry. Ovarian cancer awareness month: progress and challengesSeptember marks the month of ovarian cancer awareness. Ovarian cancer is the deadliest gynaecological cancer. In the US, ovarian cancer mortality has fallen since the early 2000s. […]
Industry Insights: Healthcare 26th August
Industry Insights: Healthcare In this week’s insights post, we explore three recent drug approvals that may be groundbreaking in disease treatment. Semaglutide gets approval for MASH with fibrosis The US Food and Drug Administration (FDA) has granted approval to semaglutide (Wegovy; Novo Nordisk) as the first GLP-1 receptor agonist indicated for metabolic dysfunction–associated steatohepatitis (MASH) […]
Industry Insights: Healthcare 31st July
Industry Insights Healthcare: 31/07/25 This week’s insights post discusses three of the most recent advancements and hot topics in the healthcare industry. GLP-1 agonists: potential therapies in ovarian cancer A recent study from Gynecologic Oncology highlighted that GLP-1 (glucagon-like peptide-1) receptor agonists improved overall survival in women with ovarian cancer, the deadliest gynaecologic cancer. […]
